| http://www.w3.org/ns/prov#value | - Over recent decades, drug companies have "streamlined standard clinical procedures to improve chances for FDA approval.Randomization of patient selection has been replaced with run-up and pre-trial adjustment periods, in which test subjects are removed from the study whose responses make placebos look too good or the drug too toxic.
|
